These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30116742)

  • 1. Effect of Insulin-Induced Lipodystrophy on Glycemic Control among Children and Adolescents with Diabetes in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Tsadik AG; Atey TM; Nedi T; Fantahun B; Feyissa M
    J Diabetes Res; 2018; 2018():4910962. PubMed ID: 30116742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study.
    Singha A; Bhattacharjee R; Dalal BS; Biswas D; Choudhuri S; Chowdhury S
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):503-508. PubMed ID: 33662195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study.
    Abera RG; Demesse ES; Boko WD
    BMC Endocr Disord; 2022 Mar; 22(1):54. PubMed ID: 35249547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    Tekalegn Y; Addissie A; Kebede T; Ayele W
    PLoS One; 2018; 13(3):e0193442. PubMed ID: 29505602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of lipodystrophy induced by recombinant human insulin.
    Hajheydari Z; Kashi Z; Akha O; Akbarzadeh S
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1196-201. PubMed ID: 22165682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus.
    Bertuzzi F; Meneghini E; Bruschi E; Luzi L; Nichelatti M; Epis O
    J Endocrinol Invest; 2017 Oct; 40(10):1107-1113. PubMed ID: 28452000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India.
    Gupta SS; Gupta KS; Gathe SS; Bamrah P; Gupta SS
    Diabetes Technol Ther; 2018 Jul; 20(7):483-491. PubMed ID: 29932731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical lipohypertrophy--Easily ignored complications of insulin therapy.
    Luo D; Shi Y; Zhu M; Wang H; Yan D; Yu J; Ji J; Liu X; Fan B; Xu Y; Zhang M; He W; Xu J; Yang T
    J Diabetes Complications; 2021 Mar; 35(3):107806. PubMed ID: 33280982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-glycemic Adverse Effects of Insulin.
    Guarneri AM; Hoffman RP
    Curr Diabetes Rev; 2022; 18(2):e012821190877. PubMed ID: 33511950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes.
    Raile K; Noelle V; Landgraf R; Schwarz HP
    Exp Clin Endocrinol Diabetes; 2001; 109(8):393-6. PubMed ID: 11748486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010.
    Ji J; Lou Q
    Curr Med Res Opin; 2014 Jun; 30(6):1087-93. PubMed ID: 24552616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
    Hauner H; Stockamp B; Haastert B
    Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes.
    Lombardo F; Bombaci B; Alibrandi A; Visalli G; Salzano G; Passanisi S
    Children (Basel); 2022 Jul; 9(7):. PubMed ID: 35884071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-induced lipodystrophy and predisposing factors in children and adolescents with type 1 diabetes mellitus (T1DM) in a tertiary care Egyptian center.
    Elsayed S; Soliman AT; De Sanctis V; Fawzy D; Ahmed S; Alaaraj N
    Acta Biomed; 2023 Jun; 94(3):e2023078. PubMed ID: 37326270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: A prospective cohort study in China.
    Wang W; Huang R; Chen Y; Tu M
    Medicine (Baltimore); 2021 Jul; 100(29):e26743. PubMed ID: 34398053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local complications of insulin administration sites and effect on diabetes management.
    Demir G; Er E; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Nurs; 2022 Sep; 31(17-18):2530-2538. PubMed ID: 34622517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact.
    Ji L; Sun Z; Li Q; Qin G; Wei Z; Liu J; Chandran AB; Hirsch LJ
    Diabetes Technol Ther; 2017 Jan; 19(1):61-67. PubMed ID: 28099050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Errors in insulin treatment management and risk of lipohypertrophy.
    Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
    Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipohypertrophy Effect on Glycemic Profile in an Adult With Type 1 Diabetes Using Scanned Continuous Glucose Monitoring.
    Oriot P; Hermans MP
    J Diabetes Sci Technol; 2020 Mar; 14(2):500-501. PubMed ID: 31847568
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.
    Vardar B; Kizilci S
    Diabetes Res Clin Pract; 2007 Aug; 77(2):231-6. PubMed ID: 17303282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.